Results 31 to 40 of about 121,416 (310)

Selectivity in genetic association with sub-classified migraine in women. [PDF]

PLoS Genetics, 2014
Migraine can be sub-classified not only according to presence of migraine aura (MA) or absence of migraine aura (MO), but also by additional features accompanying migraine attacks, e.g. photophobia, phonophobia, nausea, etc.
Daniel I Chasman, Verneri Anttila, Julie E Buring, Paul M Ridker, Markus Schürks, Tobias Kurth, International Headache Genetics Consortium   +6 more
doaj   +1 more source

Migraine in the workplace

eNeurologicalSci, 2022
Migraine is prevalent, disabling, and peaks during people's peak productive years. The impact of migraine on people's professional lives, work productivity, and interpersonal relationships at work eventually affects everyone, has a significant ...
Olivia Begasse de Dhaem, Fumihiko Sakai
doaj   +1 more source

The Impact of Biseasonal Time Changes on Migraine

Neurology International
Background: Changes in the daily rhythm can trigger migraine attacks. The sensitivity for triggering attacks is closely linked to the regulation of biological rhythms controlled by the hypothalamus.
Carl H. Göbel, Katja Heinze-Kuhn, Axel Heinze, Anna Cirkel, Hartmut Göbel   +4 more
doaj   +1 more source

Estimation of migraine prevalence considering active and inactive states across different age groups

The Journal of Headache and Pain, 2023
Background Migraine is a very common headache disorder on the population level, characterized by symptomatic attacks (activity). For many people with migraine, the migraine symptoms intermittently or permanently cease during their lifetime (inactive ...
Marco Piccininni, Ralph Brinks, Jessica L. Rohmann, Tobias Kurth   +3 more
doaj   +1 more source

Chronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives

Frontiers in Pain Research, 2021
Chronic migraine is a disabling neurological disorder that imposes a considerable burden on individual and socioeconomic outcomes. Chronic migraine is defined as headaches occurring on at least 15 days per month with at least eight of these fulfilling ...
Tiffani J. Mungoven, Luke A. Henderson, Noemi Meylakh   +2 more
doaj   +1 more source

Evaluating Treatment Success in CGRP Antibody Prophylaxis: A Retrospective Cohort Study Comparing Monthly Migraine Days, MIDAS Scores, and HIT-6 Scores

Pain and Therapy
Introduction Monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) or its receptor represent a major advance in migraine prevention. However, standardized criteria for assessing treatment response are lacking.
Carl H. Göbel, Axel Heinze, Katja Heinze-Kuhn, Ursula Müller, Anna Cirkel, Hartmut Göbel   +5 more
doaj   +1 more source

Early antiseizure response to cenobamate (200 mg/day) in focal drug-resistant epilepsy: a retrospective single-center analysis

Epilepsy & Behavior Reports
Clinical studies have shown cenobamate (CNB) is effective for treating drug-resistant focal epilepsy. This study examines Polish patients with epilepsy, assessing the efficacy and safety of CNB at 200 mg/day and factors influencing early therapeutic ...
Ewa Czapińska-Ciepiela, Agnieszka Kondak, Monika Kowalczyk, Piotr Czapiński   +3 more
doaj   +1 more source

The Chronic Migraine Brain: What Have We Learned From Neuroimaging?

Frontiers in Neurology, 2020
Chronic migraine is a highly disabling disease with a great impact on socioeconomic functioning and quality of life of migraine patients. Chronic migraine usually evolves from episodic migraine that gradually increases in attack frequency, supporting the
Massimo Filippi, Massimo Filippi, Massimo Filippi, Roberta Messina, Roberta Messina   +4 more
doaj   +1 more source

Vestibular Patient Journey: Insights From Vestibular Disorders Association (VeDA) Registry

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Vestibular symptoms impose a high burden of disability. Understanding real‐world diagnostic and treatment pathways can identify care gaps and guide interventions. We aimed to characterize symptom profiles, diagnostic trends, provider involvement, and treatment patterns in vestibular disorders.
Ali Rafati, Sami I. Nassar, Shaun A. Nguyen, Patricia L. Gerend, Michael C. Schubert, Michael T. Teixido, Frederick A. Godley, Joel A. Goebel, Cynthia A. Ryan, Habib G. Rizk, Amir Kheradmand   +10 more
wiley   +1 more source

Rizatriptan as an Over-the-Counter Triptan in the Treatment of Migraine Attacks

Pain and Therapy
Around 91% of migraine patients use over-the-counter medicines to treat attacks, often without further treatment or medical consultation. This therapeutic principle is established in most countries, regardless of how the healthcare system is otherwise ...
Carl H. Göbel, Axel Heinze, Anna Cirkel, Hartmut Göbel   +3 more
doaj   +1 more source